South Korea · Delayed Price · Currency is KRW Kwang Dong Pharmaceutical Statistics
Total Valuation
KRX:009290 has a market cap or net worth of KRW 222.16 billion. The enterprise value is 406.35 billion.
| Market Cap | 222.16B |
| Enterprise Value | 406.35B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | Mar 31, 2026 |
Share Statistics
KRX:009290 has 36.66 million shares outstanding. The number of shares has increased by 7.51% in one year.
| Current Share Class | 36.66M |
| Shares Outstanding | 36.66M |
| Shares Change (YoY) | +7.51% |
| Shares Change (QoQ) | +16.00% |
| Owned by Insiders (%) | 13.97% |
| Owned by Institutions (%) | 27.83% |
| Float | 29.51M |
Valuation Ratios
The trailing PE ratio is 12.02.
| PE Ratio | 12.02 |
| Forward PE | n/a |
| PS Ratio | 0.13 |
| PB Ratio | 0.31 |
| P/TBV Ratio | 0.38 |
| P/FCF Ratio | 7.28 |
| P/OCF Ratio | 4.25 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.52, with an EV/FCF ratio of 13.32.
| EV / Earnings | 18.79 |
| EV / Sales | 0.24 |
| EV / EBITDA | 8.52 |
| EV / EBIT | 14.42 |
| EV / FCF | 13.32 |
Financial Position
The company has a current ratio of 1.30, with a Debt / Equity ratio of 0.42.
| Current Ratio | 1.30 |
| Quick Ratio | 0.87 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 5.50 |
| Debt / FCF | 9.87 |
| Interest Coverage | 3.16 |
Financial Efficiency
Return on equity (ROE) is 3.34% and return on invested capital (ROIC) is 2.99%.
| Return on Equity (ROE) | 3.34% |
| Return on Assets (ROA) | 1.78% |
| Return on Invested Capital (ROIC) | 2.99% |
| Return on Capital Employed (ROCE) | 4.46% |
| Weighted Average Cost of Capital (WACC) | 4.05% |
| Revenue Per Employee | 1.66B |
| Profits Per Employee | 21.18M |
| Employee Count | 1,021 |
| Asset Turnover | 1.36 |
| Inventory Turnover | 6.88 |
Taxes
In the past 12 months, KRX:009290 has paid 10.15 billion in taxes.
| Income Tax | 10.15B |
| Effective Tax Rate | 31.41% |
Stock Price Statistics
The stock price has increased by +7.07% in the last 52 weeks. The beta is 0.34, so KRX:009290's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | +7.07% |
| 50-Day Moving Average | 7,906.00 |
| 200-Day Moving Average | 6,798.20 |
| Relative Strength Index (RSI) | 24.17 |
| Average Volume (20 Days) | 238,758 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:009290 had revenue of KRW 1.69 trillion and earned 21.62 billion in profits. Earnings per share was 504.24.
| Revenue | 1.69T |
| Gross Profit | 307.26B |
| Operating Income | 35.26B |
| Pretax Income | 32.32B |
| Net Income | 21.62B |
| EBITDA | 54.80B |
| EBIT | 35.26B |
| Earnings Per Share (EPS) | 504.24 |
Balance Sheet
The company has 182.71 billion in cash and 301.19 billion in debt, with a net cash position of -118.48 billion or -3,232.00 per share.
| Cash & Cash Equivalents | 182.71B |
| Total Debt | 301.19B |
| Net Cash | -118.48B |
| Net Cash Per Share | -3,232.00 |
| Equity (Book Value) | 712.31B |
| Book Value Per Share | 13,075.18 |
| Working Capital | 157.86B |
Cash Flow
In the last 12 months, operating cash flow was 52.23 billion and capital expenditures -21.72 billion, giving a free cash flow of 30.51 billion.
| Operating Cash Flow | 52.23B |
| Capital Expenditures | -21.72B |
| Depreciation & Amortization | 19.54B |
| Net Borrowing | -12.79B |
| Free Cash Flow | 30.51B |
| FCF Per Share | 832.19 |
Margins
Gross margin is 18.15%, with operating and profit margins of 2.08% and 1.28%.
| Gross Margin | 18.15% |
| Operating Margin | 2.08% |
| Pretax Margin | 1.91% |
| Profit Margin | 1.28% |
| EBITDA Margin | 3.24% |
| EBIT Margin | 2.08% |
| FCF Margin | 1.80% |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 1.59%.
| Dividend Per Share | 100.00 |
| Dividend Yield | 1.59% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 18.17% |
| Buyback Yield | -7.51% |
| Shareholder Yield | -5.92% |
| Earnings Yield | 9.73% |
| FCF Yield | 13.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 26, 1999. It was a forward split with a ratio of 5.
| Last Split Date | Apr 26, 1999 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
KRX:009290 has an Altman Z-Score of 2.31 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.31 |
| Piotroski F-Score | 6 |